Tolley Health Economics understands the importance of serving the pharmaceutical and health economics profession that comes from publication of research studies in peer-review journals. It is important to our health outcomes discipline that we help create new ideas, advance methods, challenge widely held views, and influence others with our growing knowledge base, which in turn can benefit others to feel connected to the profession.

From Tolley Health Economics inception in 2008, Keith Tolley has written and co-authored publications in a wide range of therapeutic areas.

Our experience in preparing manuscripts for publication, formed from several years working in academia, will enable us to work with you on content and communication of your research, and to devise a strategy to respond to the specifications required from the selected journal.

Kay S, Tolley K, Colayco D, Khalaf K, Anderson P, Globe D.
Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder. Value in Health [in press]. Click Here

Vegter S, Tolley K, Keith MS, Postma MJ.
Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis – Value in Health Click Here

Vissers DC, Lenre M, Tolley K, Jakobsson J, Sendersky V, Jansen JP.
An Economic Evaluation of Short-Acting Opioids for Treatment of Breakthrough Pain in Patients with Cancer – Value Health Click Here

Keith Tolley, MPhil Health Economist and Director, Tolley Health Economics Ltd
What Are Health Utilities Click Here

Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections Click Here

Cost Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosatemia in Dialysis Patients – A Canadian Payer Perspective Click Here

Utility Elicitation Study in the UK General Public for Late-Stage Chronic Lymphocytic Leukaemia Click Here

Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload Click Here

Tolley K, Kemmett D, Thybo S, Nasr R, Smethurst H
A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective

Kay S, Strickson A, Puelles J, Selby R, Benson E, Tolley K.

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis Click Here

Tolley K, Argenziano G, Calzavara-Pinton PG, Larsson T, Ryttig L.

Pharmacoeconomic evaluations in the treatment of actinic keratosis. Click here

Gabrielle Nayroles, Sandrine Frybourg, Sylvie Gabriel, Åsa Kornfeld,Fernando Antoñanzas-Villar, Jaime Espín, Claudio Jommi, Nello Martini,Gérard de Pouvourville, Keith Tolley, Jürgen Wasem & Mondher Toumi

Unlocking the potential of established products: toward new incentives rewarding innovation in Europe Click here

Rebecca Harvey

Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling Methods Click here 


At Tolley Health Economics we know the importance of presenting research projects at national and international peer-attended conferences to enhance reimbursement of your pharmaceutical product. Conference presentations via oral presentations or poster sessions allow presentation of data during many stages of development, (e.g., preliminary findings, recently collected data, or data that is waiting to be published). This will allow the presentation of the most up-to-date findings whilst receiving feedback from colleagues.

Keith Tolley has a history of conference presentations and chairing workshops at national and international health outcomes conferences, namely ISPOR (International Society of Pharmacoeconomics and Outcomes Research). This wealth of experience demonstrates Keith’s ability to deliver his research in a clear and meaningful way, present data to a range of individuals (who may or may not be familiar with his field of research) and to manage specific questions from the audience.

In addition, Keith has established many health economic contacts from attendance and participation at key symposia, thereby creating a global network for collaboration projects.

Our history of conference presentations at Tolley Health Economics will demonstrate to you that we can disseminate your research finding to colleagues as well as keep up-to-date with the health economics discipline.

EHC Presentation Latvia 20th Sept HTA Payer Perspective v1
Tolley Presentation Reimbursement Policies Across Europe IDF Europe Symposium Sept 30th 2012
Economics of Haemophilia presentation July 2012